Oliver Spadiut in the lab
Oliver Spadiut in the lab When proteins are produced in the pharmaceutical industry, they are often initially misfolded and have to be rearranged. At TU Wien, this is being studied in detail in a new CD laboratory . Certain proteins are among the most important products of the pharmaceutical industry - such as insulin or interferons, which are used to treat diabetes, cancer or viral diseases. However, when such proteins are produced artificially, there is always a problem: they are initially folded incorrectly. Instead of a functional protein, you get what is known as an inclusion body, which first has to be brought into the correct shape in laborious and expensive steps. A new Christian Doppler Laboratory has now been opened at TU Wien - with the support of corporate partner Boehringer Ingelheim RCV and the Federal Ministry of Labor and Economics. Research is now being carried out there into how the inclusion bodies can be brought into the right shape most efficiently.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
